Nephropathology Since 2006
   
Case 185
Diagnosis
 
     
Versión en Español

Go back to clinical information and images

Diagnosis: IgG4-Related Disease

Immunoglobulin G4-related diseases (IgG4-RDs) is a clinical entity that often involves multiple organs and is characterized by high levels of serum IgG4, dense infiltration of IgG4+ cells and storiform fibrosis. Cellular immunity, particularly T-cell mediated immunity, has been implicated in the pathogenesis of IgG4-RDs. The most frequent renal manifestations of IgG4-RD are IgG4-related tubulointerstitial nephritis, membranous glomerulopathy and obstructive nephropathy secondary to urinary tract obstruction due to IgG4-related retroperitoneal fibrosis. IgG4-RD diagnosis should be based on specific histopathological findings, confirmed by tissue immunostaining, typical radiological findings and an appropriate clinical context. The first line treatment is the steroids with two warnings: Steroid resistance and relapse after discontinuation. In the case of steroid resistance, B cell depleting agents as rituximab represent the second-line treatment. In the case of relapse after discontinuation, steroid treatment may be associated with steroid sparing agents (Salvadori M, Tsalouchos A. Immunoglobulin G4-related kidney diseases: An updated review. World J Nephrol. 2018;7(1):29-40. [Full text link]).

In our case, although there was no typical storiform fibrosis, the abundance of IgG4 plasma cells, the clinical context and the confirmation of a similar involvement in the lymph nodes, with elevated serum IgG4 levels, helped us to confirm the diagnosis.

Visit the Chapter: Tubulointerstitial diseases of our Tutorial.

Go back to clinical information and images

References

  • Zeng Q, Gao J, Zhang X, Liu A, Wang Z, Wang Z, Chi X, Shi Q, Wang Y, Yang F, Liu Y, Li ZG. Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients. Sci Rep. 2021 May 17;11(1):10397. [PubMed link]
  • Adam Z, Adamová Z, Řehák Z, Koukalová R. IgG4-releated disease. Klin Onkol. 2021 Spring;34(2):92-102. [PubMed link]
  • Capecchi R, Giannese D, Moriconi D, Bonadio AG, Pratesi F, Croia C, Egidi MF, Puxeddu I, Tavoni AG, Migliorini P. Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight. Front Med (Lausanne). 2021 Mar 31;8:635706 [PubMed link].
  • Mbengue M, Goumri N, Niang A. IgG4-related kidney disease: Pathogenesis, diagnosis, and treatment. Clin Nephrol. 2021 Jun;95(6):292-302. [PubMed link]
  • Saeki T, Nagasawa T, Ubara Y, et al. Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology. Ann Rheum Dis. 2021 Jul;80(7):956-957. [PubMed link]
  • Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. [PubMed link].
  • Salvadori M, Tsalouchos A. Immunoglobulin G4-related kidney diseases: An updated review. World J Nephrol. 2018;7(1):29-40. [Full text link]

[Top]

Go back to clinical information and images